Comparison of laparoscopic vs. robotic sentinel lymph node mapping and biopsy in endometrial cancer

被引:0
作者
Harrison Odgers [1 ]
Angela Lin [2 ]
Trevor Tejada-Berges [1 ]
机构
[1] Department of Gynaecologic Oncology, Chris O’Brien Lifehouse, 119-143 Missenden Road, Camperdown, Sydney
[2] School of Medicine, The University of Sydney, Sydney
关键词
Endometrial cancer; Gynaecologic Oncology; Minimally invasive surgery; Robotic surgery; Sentinel lymph node biopsy;
D O I
10.1007/s11701-025-02300-w
中图分类号
学科分类号
摘要
We compare the success of sentinel lymph node (SLN) biopsy between standard laparoscopy and robotic-assisted laparoscopy (RAL) in patients with endometrial cancer. Patients with uterine epithelial tumour types undergoing staging surgery were identified from January 2019 to March 2023. Included patients underwent a total hysterectomy, bilateral salpingo-oophorectomy and attempted bilateral SLN biopsy with indigocyanine green (ICG) dye, utilising either standard laparoscopy or RAL. 298 patients met the inclusion criteria. 211 (70.8%) had standard laparoscopy and 87 (29.2%) underwent RAL. The RAL cohort had significantly higher median body mass index (BMI) compared to standard laparoscopy (37 vs. 28 kg/m2, p < 0.001). The overall rate of successful bilateral SLN biopsy was 66.8% (n = 199), and at least one hemi-pelvis was successfully biopsied in 87.3% (n = 260) of patients. There was no significant difference in bilateral SLN biopsy success between RAL and standard laparoscopy (60.9% vs 69.2%, p = 0.17). RAL was not predictive of bilateral SLN biopsy success in multivariate analysis (OR 1.10, p = 0.76). There was no difference in SLN biopsy location, number of nodes identified, or empty-packet dissections between the surgical approaches. Increasing age (OR 0.96, p = 0.002) and BMI (OR 0.94, p < 0.001) were significantly associated with reduced bilateral SLN biopsy success. Between the learning and experienced periods of the study, the bilateral SLN biopsy success rate improved significantly for RAL (40.6 vs. 72.7%, p = 0.03), which was not found with standard laparoscopy. The decision to perform RAL should consider multiple factors including surgeon experience. Future research should be directed towards prospective, randomised and BMI-matched cohorts. © The Author(s) 2025.
引用
收藏
相关论文
共 36 条
  • [1] Bray F., Et al., Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, Cancer J Clin, 74, 3, pp. 229-263, (2024)
  • [2] Gu B., Et al., Variations in incidence and mortality rates of endometrial cancer at the global, regional, and national levels, 1990–2019, Gynecol Oncol, 161, 2, pp. 573-580, (2021)
  • [3] Crosbie E.J., Et al., Endometrial cancer, Lancet, 399, pp. 1412-1428, (2022)
  • [4] Concin N., Et al., ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma, Int J Gynecol Cancer, 31, 1, pp. 12-39, (2021)
  • [5] Abu-Rustum N., Et al., Uterine neoplasms, version 1.2023, NCCN clinical practice guidelines in oncology, J Natl Compr Canc Netw, 21, 2, pp. 181-209, (2023)
  • [6] Rossi E.C., Et al., A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study, Lancet Oncol, 18, 3, pp. 384-392, (2017)
  • [7] Cusimano M.C., Et al., Assessment of sentinel lymph node biopsy vs lymphadenectomy for intermediate-and high-grade endometrial cancer staging, JAMA Surg, 156, 2, pp. 157-164, (2021)
  • [8] Marchocki Z., Et al., Sentinel lymph node biopsy in high-grade endometrial cancer: a systematic review and meta-analysis of performance characteristics, Am J Obstet Gynecol, 225, 4, (2021)
  • [9] Clair K.H., Tewari K.S., Robotic surgery for gynecologic cancers: indications, techniques and controversies, J Obstet Gynaecol Res, 46, 6, pp. 828-843, (2020)
  • [10] Steffens D., Et al., Surgical outcomes and cost analysis of a multi-specialty robotic-assisted surgery caseload in the Australian public health system, J Robot Surg, 17, 5, pp. 2237-2245, (2023)